Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life expectancy of 3–5 years post diagnosis. The use of complementary medicine such as medicinal cannabis in search for a potential treatment or cure is common in ALS. Preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbi, Berzenn, Broadley, Simon, Bedlack, Richard, Russo, Ethan, Sabet, Arman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858175/
https://www.ncbi.nlm.nih.gov/pubmed/31719072
http://dx.doi.org/10.1136/bmjopen-2019-029449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858175/
https://www.ncbi.nlm.nih.gov/pubmed/31719072
http://dx.doi.org/10.1136/bmjopen-2019-029449

Ejemplares similares